Literature DB >> 23927935

A longitudinal biosocial study of cortisol and peer influence on the development of adolescent antisocial behavior.

E Platje1, R R J M Vermeiren, A Raine, T A H Doreleijers, L G M T Keijsers, S J T Branje, A Popma, P A C van Lier, H M Koot, W H J Meeus, L M C Jansen.   

Abstract

It is increasingly recognized that in order to understand the complex phenomenon of antisocial behavior, interrelations between biological and social risk factors should be taken into account. In the current study, this biosocial approach was applied to examine the mediating role of deviant peers in longitudinal associations linking the level of hypothalamic-pituitary-adrenal (HPA) axis activity to aggression and rule-breaking. Participants were 425 boys and girls from the general population, who were assessed yearly at ages 15, 16, and 17. As a measure of HPA axis activity, cortisol was assessed at awakening, 30, and 60 min later (the cortisol awakening response, CAR). Participants, as well as their best friend, reported on their own aggressive and rule-breaking behavior, thereby allowing to assess bidirectional influences within friendships. Aggression was only predicted by a decreased cortisol level at awakening, and not by aggressive behavior of their friend. Decreased levels of cortisol at awakening predicted adolescents' rule-breaking, which subsequently predicted increased rule-breaking of their best friend. The latter was only found for adolescents who changed friends, as compared to adolescents with the same friend in every year. Gender differences were not found. These findings suggest that interrelations between biological and social risk factors are different for the development of aggression versus rule-breaking. Furthermore, decreased levels of HPA axis activity may represent a susceptibility to selecting deviant peers.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aggression; Cortisol; HPA axis; Longitudinal; Peer influences; Rule-breaking

Mesh:

Substances:

Year:  2013        PMID: 23927935     DOI: 10.1016/j.psyneuen.2013.07.006

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  6 in total

Review 1.  Annual Research Review: Early adversity, the hypothalamic-pituitary-adrenocortical axis, and child psychopathology.

Authors:  Kalsea J Koss; Megan R Gunnar
Journal:  J Child Psychol Psychiatry       Date:  2017-07-17       Impact factor: 8.982

Review 2.  Psychosocial functioning and the cortisol awakening response: Meta-analysis, P-curve analysis, and evaluation of the evidential value in existing studies.

Authors:  Ian A Boggero; Camelia E Hostinar; Eric A Haak; Michael L M Murphy; Suzanne C Segerstrom
Journal:  Biol Psychol       Date:  2017-09-14       Impact factor: 3.251

3.  Pubertal transition with current life stress and support alters longitudinal diurnal cortisol patterns in adolescents exposed to early life adversity.

Authors:  Brie M Reid; Carrie E DePasquale; Bonny Donzella; Keira B Leneman; Heather Taylor; Megan R Gunnar
Journal:  Dev Psychobiol       Date:  2021-05-30       Impact factor: 2.531

4.  Endogenous testosterone is associated with lower amygdala reactivity to angry faces and reduced aggressive behavior in healthy young women.

Authors:  Macià Buades-Rotger; Christin Engelke; Frederike Beyer; Brian G Keevil; Georg Brabant; Ulrike M Krämer
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

5.  The effectiveness of Dutch Cell Dogs in correctional facilities in the Netherlands: a study protocol of a quasi-experimental trial.

Authors:  Gerdien Schenk; Hanne M Duindam; Hanneke E Creemers; Machteld Hoeve; Geert Jan J M Stams; Jessica J Asscher
Journal:  BMC Psychiatry       Date:  2018-07-05       Impact factor: 3.630

6.  Post-Traumatic Bio-Behavioral Rehabilitation of Adult Female Victims.

Authors:  Kathleen Brewer-Smyth; Harold G Koenig; Katherine Kafonek; Tyler Adams; Adrian Raine; D Phil; Douglas A Granger
Journal:  Dela J Public Health       Date:  2021-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.